Orbicular Pharmaceutical Technologies Pvt Ltd

Orbicular Pharmaceutical Technologies Pvt. Ltd. is a research oriented pharmaceutical product development company with proven capabilities across various dosage forms. Our business strategy revolves around developing niche generic and specialty pharmaceutical products and licensing them at late stages to our global partners. The company ambitious strategic plan is to execute the defined CI-TOP SPIN Strategy for both Regulated and Emerging Markets. CI-TOP SPIN basically refers to Complex Injectables, Topicals , Ophthalmic, Parenterals, Nasal Sprays and Inhalations which characterizes a product domain that is complex, has entry barriers and profitable domain. We intelligently select products and proactively execute ahead of the competition exceeding regulatory expectations.

Our expertise in formulation and drug delivery technologies is applied to the development of generics, generic plus and controlled release products in addition to the development of novel products for innovator and specialty companies in multiple therapeutic areas across dosage forms.

We partner with major national and international drug manufacturers with advanced development solutions and capabilities that enable them to deliver safe drugs and very effectively meet the needs of millions of patients around the world.

We are founded by a team of experienced techno-entrepreneurs and managed by a team of professionals with decades of experience in the global pharmaceutical industry. We have a stellar team of scientists each one very renowned in their own field of expertise and obsessive about details, deadlines and results. The Team has had an excellent track record of having successfully delivered hands on from concept to commercialization.